Sitagliptin vs Tildrakizumab

## Sitagliptin vs Tildrakizumab: Overview

This comparison examines the pharmacological differences between **Sitagliptin** and **Tildrakizumab**.

## Mechanism of Action

**Sitagliptin**: DPP-4 inhibitor increasing incretin levels.

## Pharmacokinetics

**Half-life**: Sitagliptin — 12.4 hours; Tildrakizumab — N/A.

## Chemical Properties

**Molecular Formula**: Sitagliptin — C16H15F6N5O; Tildrakizumab — N/A.

**Molecular Weight**: Sitagliptin — 407.3140 g/mol; Tildrakizumab — N/A.

**Type**: Sitagliptin — Small molecule; Tildrakizumab — Antibody.